FDA Inspection 999120 — Matson, Mark A., MD, Clinical Investigator, Prism Research
The FDA completed an inspection of Matson, Mark A., MD, Clinical Investigator, Prism Research on Jan 18, 2017 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional Details
Clinical Investigator (CI)